Oct 31, 1997
3:1
For every share held, investors received 3. The price per share adjusted from $73.88 to $24.63.
The split itself did not change the total investment value.
Lineage Cell Therapeutics, Inc. (LCTX) trades on the New York Stock Exchange Arca in the Biotechnology industry.
Lineage Cell Therapeutics, Inc. company overviewThe latest split shown was on October 31, 1997. It was a 3-for-1 forward split, so shareholders received 3 shares for every share they held.
This history records one forward split, on October 31, 1997.